- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1993
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics ; volume:36 ; number:2 ; day:4 ; month:3 ; year:2022 ; pages:99-129 ; date:4.2022
Pharmaceutical medicine ; 36, Heft 2 (4.3.2022), 99-129, 4.2022
- Creator
-
Nahler, Gerhard
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40290-022-00420-4
- URN
-
urn:nbn:de:101:1-2022070306574929837257
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nahler, Gerhard
- SpringerLink (Online service)
Other Objects (12)
Cannabinoids as therapeutics
Digitoxin and its analogs as novel cancer therapeutics
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
Cannabidiol as a treatment for epilepsy
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
Novel EGFR family member binding antibodies as cancer therapeutics
Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer?
Anaplastic thyroid cancer spheroids as preclinical models to test therapeutics
SPACA6P-AS: a trailblazer in breast cancer pathobiology and therapeutics
Recent developments in mushrooms as anti-cancer therapeutics: a review
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Targeting CDK9 for anti-cancer therapeutics
Cannabinoids as therapeutics
Digitoxin and its analogs as novel cancer therapeutics
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
Cannabidiol as a treatment for epilepsy
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
Novel EGFR family member binding antibodies as cancer therapeutics
Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer?
Anaplastic thyroid cancer spheroids as preclinical models to test therapeutics
SPACA6P-AS: a trailblazer in breast cancer pathobiology and therapeutics
Recent developments in mushrooms as anti-cancer therapeutics: a review
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Targeting CDK9 for anti-cancer therapeutics
Cannabinoids as therapeutics
Digitoxin and its analogs as novel cancer therapeutics
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
Cannabidiol as a treatment for epilepsy
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
Novel EGFR family member binding antibodies as cancer therapeutics
Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer?
Anaplastic thyroid cancer spheroids as preclinical models to test therapeutics
SPACA6P-AS: a trailblazer in breast cancer pathobiology and therapeutics
Recent developments in mushrooms as anti-cancer therapeutics: a review
Cancer vaccines as promising immuno-therapeutics: platforms and current progress